Cape Verde vs Other small states: Access to anti-retroviral drugs, female
Cape Verde
98.0%
in 2024
Other small states
94.0%
in 2022
Cape Verde rank
1st
Other small states rank
1st
Access to anti-retroviral drugs, female over time
- Cape Verde
- Other small states
How they compare
Cape Verde currently reports 98.0% against 94.0% in Other small states, a difference of 4.0%.
The two have swapped places 7 times across 20 shared years of data; in 2000 it was Other small states ahead.
Cape Verde ranks 1st and Other small states ranks 1st of 141 countries.
Across the 3 decades both report, Cape Verde averaged higher in 2 and Other small states in 1.
Head to head by decade
| Decade | Cape Verde | Other small states | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.0% | 7.2% | 1.8% | Cape Verde |
| 2010s | 59.5% | 62.1% | 2.6% | Other small states |
| 2020s | 97.0% | 93.8% | 3.2% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Cape Verde or Other small states?
- Cape Verde, at 98.0% against 94.0% in Other small states as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Cape Verde and Other small states?
- 4.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Other small states?
- 20 years are reported by both, from 2000 to 2022.
- How do Cape Verde and Other small states rank globally for access to anti-retroviral drugs, female?
- Cape Verde ranks 1st and Other small states ranks 1st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.